Demoxytocin
From Wikipedia, the free encyclopedia
Demoxytocin | ||
---|---|---|
IUPAC name 2-[(1-{[13-(butan-2-yl)-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl)formamido]-N-(carbamoylmethyl)-4-methylpentanamide | ||
Identifiers | ||
CAS number | 113-78-0 | |
PubChem | 8229 | |
KEGG | D07228 | |
MeSH | deaminooxytocin | |
ChEMBL | CHEMBL435716 | |
ATC code | H01 | |
Jmol-3D images | Image 1 | |
| ||
Properties | ||
Molecular formula | C43H65N11O12S2 | |
Molar mass | 992.17 g mol−1 | |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | ||
Infobox references | ||
Demoxytocin (INN, trade name Sandopart) or deaminooxytocin, is an obstetric drug often[citation needed] used in the prevention of puerperal mastitis.[1] It is an analogue of oxytocin.
References
|
|
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.